WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker regarding Senate passage of the FDA Reauthorization Act of 2017:
Top News
Press Release | August 1, 2017
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from Chief Advocacy Officer JC Scott after introduction of bipartisan legislation (H.R. 3635) in the U.S. House of Representatives designed to ensure Medicare beneficiary access to needed medical technologies and services:
AdvaMed Statement On FDA’s Digital Health Innovation Action Plan and Pre-Cert Software Pilot Program
Press Release | July 27, 2017
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today issued the following statement from Janet Trunzo, senior executive vice president, technology and regulatory affairs, in response to FDA’s latest steps to empower consumers and advance digital health care:
Events
September
12
September 12, 2017 to September 14, 2017
| Shanghai, China The Healthcare Capital and Connections Summit is an exclusive three-day, invitation only opportunity to connect with the most relevant healthcare VCs, startups, large corporate and business partners... Read More
September
14
September 14, 2017 | Virtual Webinar
The webinar will take place from 10:00-11:00am ET
As your global presence grows, the need to effectively integrate new value chain partners into your system will become increasingly critical to... Read More
Featured Video
On June 8th AdvaMed brought together 21 member companies to showcase their latest breakthroughs in medical technology at the Capitol Visitors Center. The event was a bustling success with more than 150 people in attendance including policymakers, Hill staff, patient and provider groups, and media.
Industry News
PR Newswire
Bio2 Medical today announced the results of the Angel® Catheter pivotal study, "Evaluation of a Device Combining an Inferior Vena Cava Filter and a Central Venous Catheter for Preventing Pulmonary Embolism Among Critically Ill Trauma Patients," published in the Journal of Vascular and Interventional Radiology (JVIR). The Angel® Catheter met all safety endpoints and demonstrated a significant reduction in clinically significant and fatal pulmonary embolism (PE). The novel device was tested in a...
RealClear Health
Often undiagnosed, an estimated two to six million people in the United States have a serious heart condition called atrial fibrillation, or AFib. As those living with the disease know, complications from the irregular heartbeat caused by the AFib can be potentially devastating: The average person with AFib is five times more likely to suffer a stroke than someone with a regular heartbeat. Fortunately, there is innovative medical technology available today poised to make a real difference in...
Legal Backgrounder
When a doctor implants a medical device, he or she often requests the presence of a representative of the device manufacturer (a “rep”) in the operating room. Some observers are critical of this practice, demanding thatreps be barred from the O.R. At the same time,some lawyersthink repsin the O.R.should be subject to liability in the court system. This Legal Backgrounder explains why reps often play an important, if limited, role in the O.R., and why that role should not expose reps to lawsuits
Business Wire
ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the closing of a $36 million Series C financing, including existing convertible notes. The round was led by Philips and UPMC, through its innovation and commercialization arm UPMC Enterprises, with other new and existing investors participating. The funding will support a planned US-based pivotal trial for...
Washington Examiner
Imagine for a moment that you are one of the approximately 44 million women in the U.S. affected by cardiovascular disease, or one of the 24 million with osteoarthritis. You'd want access to the most advanced and effective care. Oftentimes, your doctor would recommend a medical technology or device as an essential component of your treatment – placing a stent in a blocked artery or replacing your knee or hip with a new artificial one, for example.
Twitter Feed
August 21, 2017 - 9:20am
Get all the latest in #medtech innovation with the 'MedTech (R)evolution' pillar at The #MedTechCon. Take a look: https://t.co/7ypGupf6ye
August 21, 2017 - 9:02am
Did you ever think of #radiotherapy as a "#superhero"? Blasting away rogue cancerous cells. @AdvaMedUpdate Visit… https://t.co/2ZbELwD4pI